DE602004028028D1 - Salze und polymorphe formen einer pyrrolsubstituierten indolinonverbindung - Google Patents

Salze und polymorphe formen einer pyrrolsubstituierten indolinonverbindung

Info

Publication number
DE602004028028D1
DE602004028028D1 DE602004028028T DE602004028028T DE602004028028D1 DE 602004028028 D1 DE602004028028 D1 DE 602004028028D1 DE 602004028028 T DE602004028028 T DE 602004028028T DE 602004028028 T DE602004028028 T DE 602004028028T DE 602004028028 D1 DE602004028028 D1 DE 602004028028D1
Authority
DE
Germany
Prior art keywords
pyrrolo
salts
polymorphic forms
indolinone compound
substituted indolinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004028028T
Other languages
German (de)
English (en)
Inventor
Andrei Blasko
Qingwu Jin
Qun Lu
Michael Anthony Mauragis
Dian Song
Brenda Sue Vonderwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Publication of DE602004028028D1 publication Critical patent/DE602004028028D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE602004028028T 2003-10-02 2004-09-20 Salze und polymorphe formen einer pyrrolsubstituierten indolinonverbindung Expired - Lifetime DE602004028028D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50810403P 2003-10-02 2003-10-02
PCT/IB2004/003070 WO2005033098A1 (en) 2003-10-02 2004-09-20 Salts and polymorphs of a pyrrole-substituted indolinone compound

Publications (1)

Publication Number Publication Date
DE602004028028D1 true DE602004028028D1 (de) 2010-08-19

Family

ID=34421700

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004028028T Expired - Lifetime DE602004028028D1 (de) 2003-10-02 2004-09-20 Salze und polymorphe formen einer pyrrolsubstituierten indolinonverbindung

Country Status (25)

Country Link
US (1) US7247627B2 (enExample)
EP (1) EP1670785B1 (enExample)
JP (1) JP4933259B2 (enExample)
KR (2) KR20060058728A (enExample)
CN (1) CN100432072C (enExample)
AR (1) AR047762A1 (enExample)
AT (1) ATE473223T1 (enExample)
AU (1) AU2004277464B2 (enExample)
BR (1) BRPI0415022A (enExample)
CA (1) CA2540639C (enExample)
CY (1) CY1110771T1 (enExample)
DE (1) DE602004028028D1 (enExample)
DK (1) DK1670785T3 (enExample)
ES (1) ES2348623T3 (enExample)
IL (1) IL174414A (enExample)
MX (1) MXPA06003661A (enExample)
NO (1) NO20061246L (enExample)
NZ (1) NZ546001A (enExample)
PL (1) PL1670785T3 (enExample)
PT (1) PT1670785E (enExample)
RU (1) RU2319702C2 (enExample)
SI (1) SI1670785T1 (enExample)
TW (1) TW200524921A (enExample)
WO (1) WO2005033098A1 (enExample)
ZA (1) ZA200602691B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182122A1 (en) * 2003-11-20 2005-08-18 Bello Carlo L. Method of treating abnormal cell growth using indolinone compounds
CA2602316A1 (en) * 2005-03-23 2006-09-28 Pfizer Products Inc. Anti-ctla4 antibody and indolinone combination therapy for treatment of cancer
CN101267824A (zh) * 2005-09-20 2008-09-17 辉瑞产品公司 使用酪氨酸激酶抑制剂的治疗剂型和方法
TWI384986B (zh) * 2007-01-17 2013-02-11 Lg Life Sciences Ltd 抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物
KR101428833B1 (ko) * 2007-04-04 2014-08-08 오츠카 가가쿠 가부시키가이샤 티탄산칼륨, 그의 제조 방법, 마찰재 및 수지 조성물
KR101129088B1 (ko) * 2008-09-17 2012-03-23 노파르티스 아게 N-[6-(시스-2,6-디메틸모르폴린-4-일)피리딘-3-일]-2-메틸-4'-(트리플루오로메톡시)[1,1'-비페닐]-3-카르복스아미드의 염
RU2430361C1 (ru) * 2010-07-05 2011-09-27 Государственное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет им. В.Ф. Войно-Ясенецкого Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования риска развития диабетической ретинопатии при сахарном диабете типа 2 у якутов
WO2012042421A1 (en) 2010-09-29 2012-04-05 Pfizer Inc. Method of treating abnormal cell growth
US9851313B2 (en) * 2015-03-03 2017-12-26 Panalytical B.V. Quantitative X-ray analysis—ratio correction

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1575936A3 (ru) * 1986-04-10 1990-06-30 Е.И.Дюпон Де Немур Энд Ко.(Фирма) Способ получени 3,3-дизамещенных индолин-2-ионов или их солей
US5534522A (en) * 1995-06-07 1996-07-09 Warner-Lambert Company (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
DE19622489A1 (de) * 1996-06-05 1997-12-11 Hoechst Ag Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters
HRP20020751B1 (hr) 2000-02-15 2011-01-31 Sugen Pirolom supstituirani 2-indolinoni kao inhibitori protein kinaze
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
SI1419151T1 (sl) 2001-08-15 2014-04-30 Pharmacia & Upjohn Company Llc Kristali, ki vključujejo sol jabolčne kisline N-(2-(dietilamino)etil)-5-((5-fluoro-1,2-dihidro-2-okso-3H-indol-3- iliden)metil)-2,4-dimetil-1H-pirol-3-karboksamida, postopki za njihovo pripravo in sestavki le-teh
YU67702A (sh) 2001-09-28 2004-12-31 Pfizer Products Inc. Postupak za dobijanje alkansulfonil piridina
TWI259081B (en) * 2001-10-26 2006-08-01 Sugen Inc Treatment of acute myeloid leukemia with indolinone compounds
JP2005528344A (ja) 2002-02-15 2005-09-22 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー インドリノン誘導体の製造法
PY0323128A (es) * 2002-09-10 2012-12-03 Pharmacia Italia Spa Formulacion sólida que comprende un compuesto de indolina, útil en el tratamiento de trastornos relacionados con proteina de quinasas

Also Published As

Publication number Publication date
SI1670785T1 (sl) 2010-10-29
JP4933259B2 (ja) 2012-05-16
HK1093068A1 (zh) 2007-02-23
WO2005033098A9 (en) 2006-05-26
NO20061246L (no) 2006-03-29
CN100432072C (zh) 2008-11-12
RU2006110541A (ru) 2006-08-27
KR20080007520A (ko) 2008-01-21
US7247627B2 (en) 2007-07-24
WO2005033098A8 (en) 2006-04-20
MXPA06003661A (es) 2006-06-05
ZA200602691B (en) 2007-06-27
IL174414A0 (en) 2008-02-09
US20050118255A1 (en) 2005-06-02
CN1863796A (zh) 2006-11-15
CA2540639A1 (en) 2005-04-14
DK1670785T3 (da) 2010-10-18
IL174414A (en) 2011-12-29
ATE473223T1 (de) 2010-07-15
WO2005033098A1 (en) 2005-04-14
ES2348623T3 (es) 2010-12-09
PL1670785T3 (pl) 2010-12-31
PT1670785E (pt) 2010-09-16
EP1670785A1 (en) 2006-06-21
RU2319702C2 (ru) 2008-03-20
AU2004277464B2 (en) 2010-07-08
NZ546001A (en) 2009-09-25
CY1110771T1 (el) 2015-06-10
JP2007507482A (ja) 2007-03-29
BRPI0415022A (pt) 2006-11-28
KR20060058728A (ko) 2006-05-30
CA2540639C (en) 2010-08-31
AU2004277464A1 (en) 2005-04-14
AR047762A1 (es) 2006-02-22
TW200524921A (en) 2005-08-01
EP1670785B1 (en) 2010-07-07

Similar Documents

Publication Publication Date Title
DE60324659D1 (de) Einrichtung zur atrialen stimulation zur vermeidung des frühen wiederauftretens einer vorhoffibrillation
ATE449762T1 (de) Kristalline formen einer biphenylverbindung
ATE499347T1 (de) Amidderivate
IL230659A (en) Calicheamicin derivative-carrier conjugates
IS7751A (is) Indól afleiður sem beta-2 meðverkandi
DK1532474T3 (da) Markering af rørforforbindelser
DE60335915D1 (de) Myostatin hemmende bindungsstoffe
IS8439A (is) Nýjar kínólín afleiður
DK1515969T3 (da) Spiroindolinpiperidinderivater
DE602006016586D1 (de) Kristalline form einer chinolin-carboxamid-verbindung
NO20052474D0 (no) Amort form av esomeprazolsalter
ATE500227T1 (de) Amidderivate
DK1652843T3 (da) Amidderivater
NO20044138L (no) Krystallinsk polymorf form av irinotekanhydroklorid
DE602005010410D1 (de) Selektive modifizierung einer vliesfläche
NO20045303D0 (no) Fremgangsmate for karakterisering av en suspensjon
ATE473223T1 (de) Salze und polymorphe formen einer pyrrolsubstituierten indolinonverbindung
DE502004004368D1 (de) Sensoranordnung einer einparkhilfe
DK1667975T3 (da) En polymorf form for 3-phenylsulfonyl-8-piperazin-1-yl-quinolin
DE602006020758D1 (de) Längslenker einer aufhängung
IS8470A (is) Notkun lífrænna efnasambanda
DK1667537T3 (da) Modermælkserstatning
ATE415523T1 (de) Bohrkopf
IS7598A (is) Ný sölt
DE602004013924D1 (de) Led-lampe zur unmittelbaren befestigung